:
The current 2019-nCoV outbreak is becoming extremely noxious and has affected the whole world. Its control
is challenging because there is no effective vaccine or drug available for Coronavirus disease. The Severe Acute
Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), previously named as 2019 novel Coronavirus (2019-nCoV),
primarily targets the human respiratory system to lung lesions and lethal pneumonia. Natural products have always shown
a crucial role in the process of drug development against various diseases. They could be leads for further drug
development to combat emergent mutants of the coronavirus. In this review, the current status of natural compounds and
their derivatives acting against different species of CoV are discussed.
Severe acute respiratory syndrome‐coronavirus‐2: Current advances in therapeutic targets and drug development
